PL2291543T3 - Markery genetyczne do kontrolowania masy ciała i sposoby ich stosowania - Google Patents

Markery genetyczne do kontrolowania masy ciała i sposoby ich stosowania

Info

Publication number
PL2291543T3
PL2291543T3 PL09747650T PL09747650T PL2291543T3 PL 2291543 T3 PL2291543 T3 PL 2291543T3 PL 09747650 T PL09747650 T PL 09747650T PL 09747650 T PL09747650 T PL 09747650T PL 2291543 T3 PL2291543 T3 PL 2291543T3
Authority
PL
Poland
Prior art keywords
methods
genetic markers
weight management
management
weight
Prior art date
Application number
PL09747650T
Other languages
English (en)
Inventor
Colleen Draper
Leon Wilkins
Gary Breton
Louis Perusse
Ruth Debusk
David Krempin
Shyam Ramakrishnan
Original Assignee
Orig3N Inc
Access Business Group Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orig3N Inc, Access Business Group Int Llc filed Critical Orig3N Inc
Publication of PL2291543T3 publication Critical patent/PL2291543T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
PL09747650T 2008-05-16 2009-05-15 Markery genetyczne do kontrolowania masy ciała i sposoby ich stosowania PL2291543T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5388808P 2008-05-16 2008-05-16
PCT/US2009/044076 WO2009140569A2 (en) 2008-05-16 2009-05-15 Genetic markers for weight management and methods of use thereof
EP09747650.1A EP2291543B1 (en) 2008-05-16 2009-05-15 Genetic markers for weight management and methods of use thereof

Publications (1)

Publication Number Publication Date
PL2291543T3 true PL2291543T3 (pl) 2015-09-30

Family

ID=41134677

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09747650T PL2291543T3 (pl) 2008-05-16 2009-05-15 Markery genetyczne do kontrolowania masy ciała i sposoby ich stosowania

Country Status (16)

Country Link
US (2) US20100105038A1 (pl)
EP (2) EP2947159A1 (pl)
JP (1) JP5651585B2 (pl)
KR (1) KR101668122B1 (pl)
CN (2) CN102099487B (pl)
AU (1) AU2009246199C1 (pl)
BR (1) BRPI0912727A8 (pl)
CA (2) CA2724497C (pl)
DK (1) DK2291543T3 (pl)
EA (1) EA018875B1 (pl)
ES (1) ES2539825T3 (pl)
HK (3) HK1158703A1 (pl)
MX (1) MX2010012371A (pl)
NZ (1) NZ589863A (pl)
PL (1) PL2291543T3 (pl)
WO (2) WO2009140601A2 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009140601A2 (en) * 2008-05-16 2009-11-19 Interleukin Genetics, Inc. Genetic marker weight management
US20100136561A1 (en) * 2008-05-16 2010-06-03 Interleukin Genetics, Inc. Genetic Markers for Weight Management and Methods of Use Thereof
WO2011044643A1 (en) * 2009-10-16 2011-04-21 Genetics Investments Pty. Ltd. Macronutrient sensitivity
US9554754B2 (en) * 2010-01-08 2017-01-31 Jeffrey Ruby System, method and computer program for weight, lifestyle and/or disease management integrating nutrition, exercise and behaviour management
CA2828201A1 (en) * 2010-02-24 2011-09-01 Bodysync, Inc. Methods for determining gene-nutrient interactions
JP2012000081A (ja) * 2010-06-21 2012-01-05 Haplo Pharma:Kk Ｓｎｐによる肥満化のリスクの予測
US20130138447A1 (en) * 2010-07-19 2013-05-30 Pathway Genomics Genetic based health management apparatus and methods
US8762167B2 (en) * 2010-07-27 2014-06-24 Segterra Inc. Methods and systems for generation of personalized health plans
CN102676639A (zh) * 2011-03-08 2012-09-19 重庆卡农科技有限公司 一种用于制定个体化减重方案的分子标记试剂盒
US20120295256A1 (en) * 2011-05-18 2012-11-22 Genovive Llc Weight management genetic test systems and methods
WO2013043554A1 (en) 2011-09-23 2013-03-28 Access Business Group International Llc Methods for creating recommended dietary regime
JP2013097693A (ja) * 2011-11-04 2013-05-20 Hitachi Solutions Ltd 骨粗鬆症リスク判定システム及びプログラム
US20150242935A1 (en) * 2012-08-17 2015-08-27 José Virgilio Braghetto Neto Genetic-based e-commerce systems and methods
WO2014047432A1 (en) 2012-09-21 2014-03-27 Ethicon Endo-Surgery, Inc. Clinical predictors of weight loss
US10242756B2 (en) 2012-09-21 2019-03-26 Ethicon Endo-Surgery, Inc. Systems and methods for predicting metabolic and bariatric surgery outcomes
US9250172B2 (en) 2012-09-21 2016-02-02 Ethicon Endo-Surgery, Inc. Systems and methods for predicting metabolic and bariatric surgery outcomes
CN102912452A (zh) * 2012-09-28 2013-02-06 湖北维达健基因技术有限公司 一种用于体重控制的基因芯片、制备方法、使用方法及其试剂盒
CN103678874B (zh) * 2013-10-14 2016-06-29 冯力新 一种个人健康膳食与运动能量平衡管理方法
CN103834739A (zh) * 2014-03-13 2014-06-04 上海中优门诊部有限公司 一种脂质代谢型肥胖基因体质评估的方法
WO2016049917A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for obesity related diseases
WO2016049927A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for obesity related diseases
CN105586395A (zh) * 2014-11-17 2016-05-18 武汉白原科技有限公司 一种人体对日常饮食反应的检测试剂盒和方法
CN105671138A (zh) * 2014-11-18 2016-06-15 武汉白原科技有限公司 一种饮食对肥胖影响的检测试剂盒和方法
CN105132566A (zh) * 2015-09-21 2015-12-09 上海中优生物高科技有限责任公司 毒素堆积型肥胖基因个体化干预饮品的制备方法及其系统
AU2017207341A1 (en) 2016-01-12 2018-08-02 Interleukin Genetics, Inc. Methods for predicting response to treatment
CN105821136A (zh) * 2016-04-29 2016-08-03 上海弥健生物科技有限公司 个性化基因分型指导健身减肥的方法及其设备应用
CN107252088A (zh) * 2016-08-26 2017-10-17 云健康基因科技（上海）有限公司 一种用于脂类代谢异常型肥胖症的食品的制备方法
US20180144820A1 (en) 2016-10-24 2018-05-24 Habit, Llc System and method for implementing meal selection based on vitals, genotype and phenotype
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
CN110494880A (zh) * 2017-01-27 2019-11-22 欧瑞3恩公司 基于个人基因轮廓来判定和展现购买建议的系统和方法
RU2691145C2 (ru) * 2017-10-09 2019-06-11 Общество с ограниченной ответственностью "Национальный центр генетических исследований" Способ формирования индивидуальных диетических рекомендаций на основе ДНК анализа
US11315684B2 (en) 2019-04-04 2022-04-26 Kpn Innovations, Llc. Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US11322255B2 (en) 2019-04-04 2022-05-03 Kpn Innovations, Llc. Methods and systems for self-fulfillment of an alimentary instruction set based on vibrant constitutional guidance
US11222727B2 (en) 2019-04-04 2022-01-11 Kpn Innovations, Llc Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US10553316B1 (en) 2019-04-04 2020-02-04 Kpn Innovations, Llc Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19
US11594316B2 (en) 2020-05-04 2023-02-28 Kpn Innovations, Llc. Methods and systems for nutritional recommendation using artificial intelligence analysis of immune impacts
US11875889B2 (en) 2020-05-29 2024-01-16 Kpn Innovations, Llc. Methods and systems of alimentary provisioning
US11393572B2 (en) 2020-11-03 2022-07-19 Kpn Innovations, Llc. System and method for modifying a nutrition requirement
US11145401B1 (en) 2020-12-29 2021-10-12 Kpn Innovations, Llc. Systems and methods for generating a sustenance plan for managing genetic disorders
US20230170073A1 (en) 2022-03-04 2023-06-01 Mohsin Mehdi Automated personalized nutrition and lifestyle recommendation system and associated method thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4998617A (en) 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
US5459039A (en) 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
CA2153387A1 (en) 1993-01-07 1994-07-21 Hubert Koester Dna sequencing by mass spectrometry
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US20030091687A1 (en) * 2001-11-13 2003-05-15 Copelan James Bradford Healthy diet system
US20030204412A1 (en) * 2002-04-29 2003-10-30 John Brier Apparatus and method for providing on-line customized nutrition, fitness, and lifestyle plans based upon a user profile and goals
JP2004105145A (ja) * 2002-09-20 2004-04-08 Japan Science & Technology Corp 心血管疾患、肥満および生活習慣病の遺伝的リスクを簡便に判定する方法
KR101177138B1 (ko) * 2003-09-12 2012-08-24 인터레우킨 제네틱스, 인코포레이티드 건강 상태를 조절하기 위한 프로그램
US20050191678A1 (en) * 2004-02-12 2005-09-01 Geneob Usa Inc. Genetic predictability for acquiring a disease or condition
JP2006067866A (ja) * 2004-09-01 2006-03-16 Toshihide Yoshida 肥満関連遺伝子及びその利用
US20060252050A1 (en) * 2005-05-06 2006-11-09 Ordovas Jose M Genetic marker for weight regulation
US20090222282A1 (en) * 2005-09-15 2009-09-03 Trustees Of Tufts College Method for Personalized Diet Design
WO2007044470A2 (en) * 2005-10-05 2007-04-19 Trustees Of Tufts College Method for personalized diet design for females of asian origin
US20070111217A1 (en) * 2005-11-14 2007-05-17 Julieta Uthurralt Quantitative trait locus prognostic for changes in regional adiposity and BMI in Caucasian males
US20070196841A1 (en) * 2006-01-20 2007-08-23 Gualberto Ruano Physiogenomic method for predicting response to diet
JP5686333B2 (ja) * 2006-02-02 2015-03-18 Ｇ＆Ｇサイエンス株式会社 心筋梗塞の遺伝的リスク検出法
US20070218107A1 (en) * 2006-03-14 2007-09-20 Schnur Steven A Method of dieting and tools for implementing same
US20080171335A1 (en) * 2006-11-30 2008-07-17 Trustees Of Tufts College Method for personalized diet design
WO2009140601A2 (en) * 2008-05-16 2009-11-19 Interleukin Genetics, Inc. Genetic marker weight management

Also Published As

Publication number Publication date
HK1218937A1 (zh) 2017-03-17
ES2539825T3 (es) 2015-07-06
CN102099487A (zh) 2011-06-15
EP2291543A2 (en) 2011-03-09
CA2724497C (en) 2018-10-09
BRPI0912727A2 (pl) 2017-08-29
WO2009140601A2 (en) 2009-11-19
AU2009246199A1 (en) 2009-11-19
DK2291543T3 (en) 2015-06-01
AU2009246199C1 (en) 2016-08-11
CA3015564A1 (en) 2009-11-19
WO2009140569A2 (en) 2009-11-19
US20100105038A1 (en) 2010-04-29
KR101668122B1 (ko) 2016-10-20
HK1217972A1 (zh) 2017-01-27
WO2009140601A3 (en) 2010-04-08
KR20110018909A (ko) 2011-02-24
EA201071319A1 (ru) 2011-06-30
MX2010012371A (es) 2011-05-23
JP5651585B2 (ja) 2015-01-14
CN102099487B (zh) 2015-08-26
EP2947159A1 (en) 2015-11-25
NZ589863A (en) 2012-11-30
JP2011520453A (ja) 2011-07-21
BRPI0912727A8 (pt) 2017-10-03
EP2291543B1 (en) 2015-04-15
HK1158703A1 (zh) 2012-07-20
CN105154525A (zh) 2015-12-16
CA3015564C (en) 2020-06-02
CA2724497A1 (en) 2009-11-19
WO2009140569A3 (en) 2010-01-14
US20100098809A1 (en) 2010-04-22
EA018875B1 (ru) 2013-11-29
CN105154525B (zh) 2019-09-17
AU2009246199B2 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
HK1218937A1 (zh) 用於體重管理的遺傳標記物及其使用方法
EP2501828A4 (en) GENETIC MARKERS FOR WEIGHT MANAGEMENT AND METHODS OF USING THE SAME
ZA201204921B (en) Combined use of vip3ab and cry1fa for management of resistant insects
ZA201200723B (en) Axmi-192 family of pesticidal genes and methods for their use
IL211299A0 (en) Pd-1 antagonists and methods of use thereof
EP2464755A4 (en) METHODS AND KITS FOR MARKING THE 3 'END OF RNA
IL216054A0 (en) Methods and compositions for evaluating genetic markers
HK1172896A1 (zh) 化合物和使用方法
EP2344943A4 (en) SURFACE PROCESSING AND MANAGEMENT OF WINDOW-SPECIFIC CONTROLS
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
HK1161094A1 (en) Compounds and methods of use
IL206619A0 (en) Genetic markers of mental illness
HK1149933A1 (en) Diazacarbazoles and methods of use
IL211764A0 (en) Markers of induced pluripotent stem cells
IL212570A0 (en) Composiitons and methods for inhibiting expression of factor vii genes
AP2008004406A0 (en) Methods of managing timberland
EP2414543A4 (en) GENETIC MARKERS FOR RISK ASSESSMENT OF URBAN LAYERS AND APOPLEXIA
IL206125A0 (en) Azaindolizines and methods of use
EP2201133A4 (en) METHOD OF USING GENETIC MARKERS AND RELATED EPISTATIC INTERACTIONS
IL209548A0 (en) Diazacarbazoles and methods of use
GB0806281D0 (en) Markers of Oocyte viability
ZA201205057B (en) Fungicidal compounds and methods of their use
AP2784A (en) Methods of managing timberland
EP2242367A4 (en) REL INHIBITORS AND METHODS OF USE
EP2539463A4 (en) MARKER FOR ADIPOSITAS AND METHOD FOR THEIR USE